Authors: CONZEN SD KAUFMAN PA ARVIZU C LEMARBRE P MAURER LH MOTT LA MILLS LE

Citation: Sd. Conzen et al., PHASE-II TRIAL OF TAMOXIFEN, ETOPOSIDE, MITOXANTRONE, AND CISPLATIN IN PATIENTS WITH METASTATIC BREAST-CARCINOMA, Cancer, 78(9), 1996, pp. 1906-1911

Authors: MOORE LW ACCHIARDO SR SMITH SO KAUFMAN PA BURK LB SMITH SJ

Citation: Lw. Moore et al., METHODS OF IMPROVING DIALYSIS ADEQUACY THROUGH INCREASED DIALYSIS DELIVERY, Journal of the American Society of Nephrology, 6(3), 1995, pp. 610-610

Authors: VALONE FH KAUFMAN PA GUYRE PM LEWIS LD MEMOLI V DEO Y GRAZIANO R FISHER JL MEYER L MROZEKORLOWSKI M WARDWELL K GUYRE V MORLEY TL ARVIZU C FANGER MW

Citation: Fh. Valone et al., PHASE IA IB TRIAL OF BISPECIFIC ANTIBODY MDX-210 IN PATIENTS WITH ADVANCED BREAST OR OVARIAN-CANCER THAT OVEREXPRESSES THE PROTOONCOGENE HER-2/NEU/, Journal of clinical oncology, 13(9), 1995, pp. 2281-2292

Authors: VALONE FH KAUFMAN PA FANGER MW GUYRE PM SPRINGGATE C

Citation: Fh. Valone et al., BISPECIFIC MONOCLONAL-ANTIBODY THERAPY (ANTI-HER-2 NEU X ANTI-CD-64) FOR HUMAN BREAST CANCERS THAT OVEREXPRESS HER-2 NEU, Journal of cellular biochemistry, 1993, pp. 255-256

Authors: KAUFMAN PA DYKERS CR CALDWELL C

Citation: Pa. Kaufman et al., WHY GOING ONLINE FOR CONTENT-ANALYSIS CAN REDUCE RESEARCH RELIABILITY, Journalism quarterly, 70(4), 1993, pp. 824-832